Other Events ·
Relay Therapeutics, Inc. filed a Certificate of Second Amendment to its Fourth Amended and Restated Certificate of…
RLAYRelay Therapeutics, Inc.
Relay Therapeutics, Inc. filed a Certificate of Second Amendment to its Fourth Amended and Restated Certificate of Incorporation on June 9, 2026, to increase the number of authorized shares of common stock from 300,000,000 to 450,000,000. The company's stockholders' Annual Meeting held on the same date also elected Douglas S. Ingram and Claire Mazumdar, Ph.D. to class III directors. Relay Therapeutics, Inc. is a biotechnology company focused on developing protein-based therapeutics.